OncLive SOSS

HER2-Positive Colorectal Cancer: Novel Approaches - Episode 1

Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes

April 7, 2023

Tanios S. Bekaii-Saab, MD, Mayo Clinic, Cathy Eng, MD, FACP, FASCO, Vanderbilt-Ingram Cancer Center, Pashtoon M. Kasi, MD, MBBS, MS, Aparna R. Parikh, MD

Opening their discussion on colorectal cancer, expert panelists consider its growing prevalence and highlight key molecular subtypes.

Video Player is loading.

Current Time 0:00

Duration 0:00

Loaded: 0%

Stream Type LIVE

Remaining Time 0:00

EP. 1: Colorectal Cancer: Prevalence, Workup, and Molecular Subtypes

EP. 2: Colorectal Cancer: An Overview on Molecular Profiling

EP. 3: Role of HER2 Expression in Colorectal Cancer

EP. 4: Role of Circulating Tumor DNA Testing in Colorectal Cancer

EP. 5: Treatment Algorithm for Metastatic Colorectal Cancer

EP. 6: HER2-Amplified Colorectal Cancer: Clinical Trial Data

EP. 7: Real-World Use of HER2-Directed Therapies in Colorectal Cancers

EP. 8: Evolutions in the HER2-Amplified CRC Treatment Landscape

EP. 9: Audience Q&A: Best Practices in Managing HER2-Amplified CRC

x